{"id":"https://openalex.org/W2182467735","doi":null,"title":"\u03b1-Lipoic Acid is a Weak Dual PPAR\u03b1/\u03b3Agonist An Ester Derivative with Increased PPAR\u03b1/\u03b3Efficacy and Antioxidant Activity","display_name":"\u03b1-Lipoic Acid is a Weak Dual PPAR\u03b1/\u03b3Agonist An Ester Derivative with Increased PPAR\u03b1/\u03b3Efficacy and Antioxidant Activity","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2182467735","mag":"2182467735"},"language":"en","primary_location":{"id":"mag:2182467735","doi":null,"is_oa":false,"landing_page_url":"http://www.jarcet.com/articles/Vol5Iss4/16Pershadshingh.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082291452","display_name":"Jaya Rajamani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaya Rajamani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075860275","display_name":"Candy Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Candy Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Renu Deshpande","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renu Deshpande","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12915","display_name":"Biochemical Acid Research Studies","score":0.25369998812675476,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha-lipoic-acid","display_name":"alpha-lipoic acid","score":0.8989999890327454},{"id":"https://openalex.org/keywords/pparalpha-agonists","display_name":"PPAR\u03b1 agonist","score":0.7580000162124634},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":1.0},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/nuclear-receptor-ligands","display_name":"nuclear receptor ligands","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6468580961227417},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.6002494692802429},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.5851613283157349},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.5763459205627441},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5516225695610046},{"id":"https://openalex.org/C2779491571","wikidata":"https://www.wikidata.org/wiki/Q312229","display_name":"Lipoic acid","level":3,"score":0.5513691902160645},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.5054910182952881},{"id":"https://openalex.org/C7341990","wikidata":"https://www.wikidata.org/wiki/Q10331450","display_name":"PPAR agonist","level":4,"score":0.4462076723575592},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.43700093030929565},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3826948404312134},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.33670562505722046},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.218501478433609},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.08156687021255493},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2182467735","doi":null,"is_oa":false,"landing_page_url":"http://www.jarcet.com/articles/Vol5Iss4/16Pershadshingh.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.7246000170707703,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W134133824","https://openalex.org/W172036993","https://openalex.org/W1749647045","https://openalex.org/W1786911182","https://openalex.org/W1951826532","https://openalex.org/W1964171650","https://openalex.org/W1976422365","https://openalex.org/W1979356762","https://openalex.org/W1989219139","https://openalex.org/W1989541636","https://openalex.org/W2031032207","https://openalex.org/W2047591801","https://openalex.org/W2054851194","https://openalex.org/W2056379546","https://openalex.org/W2058626978","https://openalex.org/W2060052300","https://openalex.org/W2060449981","https://openalex.org/W2076875306","https://openalex.org/W2079268420","https://openalex.org/W2080142407","https://openalex.org/W2081340075","https://openalex.org/W2086910750","https://openalex.org/W2088208009","https://openalex.org/W2092816488","https://openalex.org/W2096057450","https://openalex.org/W2104224178","https://openalex.org/W2113090800","https://openalex.org/W2114952735","https://openalex.org/W2116133877","https://openalex.org/W2118029488","https://openalex.org/W2122649002","https://openalex.org/W2129697991","https://openalex.org/W2138226825","https://openalex.org/W2156336479","https://openalex.org/W2157433311","https://openalex.org/W2165989770","https://openalex.org/W2175479903","https://openalex.org/W2180470224","https://openalex.org/W2341500989","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W2758711267","https://openalex.org/W613489660","https://openalex.org/W3119195021","https://openalex.org/W1003067233","https://openalex.org/W2782339021","https://openalex.org/W2070883674","https://openalex.org/W2010907499","https://openalex.org/W2983890030","https://openalex.org/W437073783","https://openalex.org/W4231930446"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}